UBE2T and neoplasm: Beyond common E3 enzymes, the ubiquitin-conjugating enzyme E2T (UBE2T), highly expressed in NSCLC tumor tissues, induces the ubiquitin degradation of FOXO1 and activates the downstream Wnt/β-catenin signaling pathway.